# The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis

> **NCT04033562** · PHASE4 · TERMINATED · sponsor: **WellSpan Health** · enrollment: 2 (actual)

## Conditions studied

- Opioid-use Disorder
- Opioid Use
- Opioid Dependence
- Opioid Abuse
- Medication Assisted Treatment
- Infusion Catheter, Wound
- Lidopatch
- Ambu ACTion
- Pregnancy Related
- Cesarean Section

## Interventions

- **DRUG:** Lidocaine patch
- **DEVICE:** Ambu ACTion pump, 0.125% bupivacaine at 8cc/hr

## Key facts

- **NCT ID:** NCT04033562
- **Lead sponsor:** WellSpan Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-15
- **Primary completion:** 2021-05-17
- **Final completion:** 2021-05-17
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** limited enrollment and unable to enroll subjects to reach statistical significance
- **Last updated:** 2021-06-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04033562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04033562, "The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04033562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*